Charles Cashion - Net Worth and Insider Trading
Charles Cashion Net Worth
The estimated net worth of Charles Cashion is at least $59,735 dollars as of 2024-04-26. Charles Cashion is the SVP, Finance, CFO and Sec. of Conatus Pharmaceuticals Inc and owns about 106,666 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $59,733. Charles Cashion is also the Director of NovaBay Pharmaceuticals Inc and owns about 32 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $2. Details can be seen in Charles Cashion's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles Cashion has not made any transactions after 2013-07-24 and currently still holds the listed stock(s).
Transaction Summary of Charles Cashion
Charles Cashion Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Cashion owns 2 companies in total, including Histogen Inc (HSTO) , and NovaBay Pharmaceuticals Inc (NBY) .
Click here to see the complete history of Charles Cashion’s form 4 insider trades.
Insider Ownership Summary of Charles Cashion
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HSTO | Histogen Inc | 2013-07-24 | SVP & Finance & CFO and Sec. |
| NBY | NovaBay Pharmaceuticals Inc | 2009-08-31 | director |
Charles Cashion Latest Holdings Summary
Charles Cashion currently owns a total of 2 stocks. Among these stocks, Charles Cashion owns 106,666 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 24, 2013, with a value of $59,733 and a weighting of 100%. Charles Cashion also owns 32 shares of NovaBay Pharmaceuticals Inc (NBY) as of August 31, 2009, with a value of $2 and a weighting of 0%.
Latest Holdings of Charles Cashion
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNAT | Conatus Pharmaceuticals Inc | 2013-07-24 | 106,666 | 0.56 | 59,733 |
| NBY | NovaBay Pharmaceuticals Inc | 2009-08-31 | 32 | 0.08 | 2 |
Holding Weightings of Charles Cashion
Charles Cashion Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Cashion has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the sale of 0 shares on July 24, 2013, which brought Charles Cashion around $0.
According to the SEC Form 4 filings, Charles Cashion has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 1 shares on August 31, 2009, which cost Charles Cashion around $1,900.
Insider Trading History of Charles Cashion
- 1
Charles Cashion Trading Performance
GuruFocus tracks the stock performance after each of Charles Cashion's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Cashion is 4.73%. GuruFocus also compares Charles Cashion's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Cashion within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles Cashion's insider trading performs compared to the benchmark.
Performance of Charles Cashion
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.63 | 4.73 | 5.79 | -3.68 | -30.79 | -14.67 |
| Relative Return to S&P 500(%) | -13.53 | -3.92 | -3.83 | -6.49 | -40.07 | -25.94 |
Charles Cashion Ownership Network
Ownership Network List of Charles Cashion
Ownership Network Relation of Charles Cashion
Charles Cashion Owned Company Details
What does Histogen Inc do?
Who are the key executives at Histogen Inc?
Charles Cashion is the SVP & Finance & CFO and Sec. of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .
Histogen Inc (HSTO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Histogen Inc Insider Transactions
Charles Cashion Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Cashion. You might contact Charles Cashion via mailing address: C/o Novabay Pharmaceuticals, Inc., 5980 Horton Street, Suite 550, Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
